rss feeds Last update Concise consent forms are effectively understood by clinical trial participants, 7 minutes ago

Diabetes news

Early glycemic control with metformin cuts CVD events

(HealthDay)—For patients with type 2 diabetes who initiate metformin, early achievement of low hemoglobin A1c (HbA1c) is associated with a reduction in the subsequent risk of cardiovascular events or death, according to ...

Apr 22, 2017
popularity12 comments 0

When is it safe to drive with type 1 diabetes?

(HealthDay)—Having type 1 diabetes can raise your chances of crashing while driving, but new research offers a checklist that helps determine whether it is safe for you to get behind the wheel.

Apr 21, 2017
popularity2 comments 1

Post-biotics may help shield obese from diabetes

You've heard of pre-biotics and pro-biotics, but now you'll be hearing a lot more about post-biotics. Researchers at McMaster University have begun to identify how post-biotics, or the by-products of bacteria, lower blood ...

Apr 20, 2017
popularity90 comments 1

Nurse-led intervention helps with diabetes control

(HealthDay)—Nurse-led interventions including education and cognitive behavioral therapy can improve hemoglobin A1c (HbA1c) control, according to a study published online April 11 in the Journal of Evaluation in Clinical ...

Apr 20, 2017
popularity0 comments 0

Diabetes continues its relentless rise

(HealthDay)—Two new studies on diabetes deliver good and bad news, but the overall message is that the blood sugar disease remains a formidable public health burden.

Apr 13, 2017
popularity21 comments 0

Intestinal bacteria may protect against diabetes

A high concentration of indolepropionic acid in the serum protects against type 2 diabetes, shows a new study from the University of Eastern Finland. Indolepropionic acid is a metabolite produced by intestinal bacteria, and ...

Apr 11, 2017
popularity1 comments 0

Avocados may help combat the metabolic syndrome

A new review investigates the effects of avocados on different components of metabolic syndrome, which is a clustering of risk factors including high blood sugar, cholesterol, blood pressure, and body mass index. These risk ...

Apr 10, 2017
popularity4 comments 0

More News Stories

Postbiotic could lower glucose, inflammation in obesity

(HealthDay)—The bacterial cell wall-derived muramyl dipeptide (MDP) postbiotic lowers adipose inflammation and reduces glucose intolerance in obese mice, according to an experimental study published online April 20 in Cell ...

Sponsored account


Did you know? You can become a Medical Xpress sponsor and enjoy all our content without ads! Simply donate any amount and not only will you experience our site ad-free, but you will be part of the Science X community mission to promote science and technology knowledge.

More of today's stories

Find more news articles via sort by date page